Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

A Microphysiological Interface of Skeletal Myobundles and Inflamed Adipose Tissue for Recapitulating Muscle Dysfunction in an Obese Microenvironment

Kim S., Cao T., Wan Z., Kim J., Li Z., Ii LAR.

Laboratory Study on Type 2 Diabetes, published in Adv Healthc Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Adv Healthc Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41208702
PMCID
PMC12864593
DOI
10.1002/adhm.202502711
Citations
1

Abstract (original English)

Systemic inflammation associated with obesity impairs skeletal muscle function through paracrine signaling from intermuscular adipose tissue-adipose depots situated between adjacent skeletal muscle groups-as well as from visceral adipose tissue, which consist of infiltrating macrophages surrounding inflamed adipocytes. These signals disrupt metabolic homeostasis and reduce muscle contractility, yet existing models are limited in their ability to recapitulate the crosstalk between skeletal muscle and inflamed adipose tissue in a physiologically relevant context. To address this, a human cell-based microphysiological system is developed that combines engineered muscle tissue (EMT) with an inflamed adipose-macrophage co-culture (IAMC) to model obesity-associated muscle dysfunction. EMTs, derived from human myoblasts on micropillar devices, self-assembled into 3D contractile myobundles. IAMC are generated by co-culturing inflamed adipocytes with pro-inflammatory M1-polarized macrophages, thereby recapitulating the obese inflammatory microenvironment. EMT-IAMC co-culture significantly reduced muscle contractility. Furthermore, cytokine profiling revealed elevated levels of pro-inflammatory mediators, and transcriptomic analysis showed metabolic reprogramming in EMTs, including upregulation of genes linked to fatty acid transport and insulin resistance. Collectively, these findings u

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Muscle, SkeletalAdipose TissueAdipocytesMacrophagesHumansObesityInflammationCytokinesCoculture TechniquesTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research